Alcami Carolinas Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2320 Scientific Park Drive, Wilmington, North Carolina (NC) 28405, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 1049418 · DUNS 831351445
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-09-26
- VAIHuman Cellular, Tissue, and Gene Therapies2025-01-31
- VAIVaccines and Allergenic Products2025-01-31
- NAIDrug Quality Assurance2021-02-18
- NAIBioresearch Monitoring2019-03-07
- NAIDrug Quality Assurance2019-01-29
- NAIDrug Quality Assurance2017-02-10
- NAIDrug Quality Assurance2016-08-19
- NAIDrug Quality Assurance2014-07-16
- NAIDrug Quality Assurance2013-05-03
- VAIDrug Quality Assurance2012-03-27
- VAIDrug Quality Assurance2010-08-26
- NAIDrug Quality Assurance2009-12-04
Drugs this plant is listed as making
5 distinct drugs across 12 products name this site in their FDA label.
- AprepitantHeron Therapeutics, Inc.
- AzathioprineSalix Pharmaceuticals
- buprenorphine hydrochloride, naloxone hydrochlorideIndivior Inc.
- FexinidazoleSanofi-Aventis U.S. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.